Jakimovski, D., Zakalik, K., Awan, S., Kavak, K. S., Pennington, P., Hojnacki, D., . . . Weinstock-Guttman, B. (2022). COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections. MDPI AG.
Chicago Style (17th ed.) CitationJakimovski, Dejan, et al. COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections. MDPI AG, 2022.
MLA (9th ed.) CitationJakimovski, Dejan, et al. COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.